Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer [Phase 1]
Phase 1 trial of a biological therapy in surgically resected pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: AS703569 and Gemcitabine Combination in Advanced Malignancies [Phase 1]
Phase 1 trial of AS703569 in combination with gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) [Phase 2, Phase 3]
A neoadjuvant GTX chemotherapy regimen with chemoradiation is being studied for pancreatic cancer in Stage II/III across Phase 2 and Phase 3…
-
CLINICAL_TRIALS research · 2014-01-23Clinical Trial Update: Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer [Phase 1]
Phase 1 clinical trial evaluating a radiofrequency probe for managing unresectable bile duct and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer [Phase 2]
A Phase II study of TPI 287 in patients with advanced, unresectable pancreatic cancer was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer [Phase 2]
Phase 2 trial of oxaliplatin, gemcitabine, and erlotinib in advanced chemo-naïve pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers [Phase 2]
A Phase 2 study evaluating S-1 as second-line treatment for advanced pancreatic cancer is underway; current status is unknown.
-
CLINICAL_TRIALS research · 2014-01-14Clinical Trial Update: Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy [Phase 2]
Phase 2 clinical trial evaluating the safety and feasibility of preoperative biliary drainage before pancreatoduodenectomy in pancreatic and…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial studied the combination of docetaxel and flavopiridol in patients with refractory metastatic pancreatic cancer; the study is…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia [Phase 1, Phase 2]
A Phase 1/2 study of NC-6004 (Nanoplatin) in combination with Gemcitabine for locally advanced and metastatic pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer [NA]
A terminated clinical trial comparing medical nutrition therapy to standard care in patients with lung cancer, pancreatic cancer, or stage I…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint [Phase 2]
A Phase 2 trial evaluated the combination of panitumumab and gemcitabine for pancreatic cancer, using overall survival as the primary endpoi…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors [Phase 1]
Phase 1 trial of gemcitabine, capecitabine, and vandetanib (ZD6474) in patients with advanced solid tumors has completed, including biliary …
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay [NA]
A completed clinical trial evaluating preoperative oral immunonutrition in pancreatic cancer patients undergoing elective surgery and its ef…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Dasatinib in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A phase 2 trial assessing dasatinib in metastatic pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer [Phase 1]
This trial update reports the completion of a Phase 1 study evaluating the safety and tolerability of a PARP inhibitor in combination with g…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial update evaluating internal Y-90 microspheres with external radiation therapy (Tomotherapy) and fluorouracil for patie…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas [Phase 2]
A Phase 2 trial is evaluating gemcitabine in combination with a monoclonal antibody therapy for metastatic pancreatic cancer; the current st…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas [Phase 2]
Clinical trial comparing chemotherapy with biological therapy in pancreatic cancer patients (Phase 2).
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer [Phase 1]
Phase 1 clinical trial update for LMB-9 immunotoxin in patients with advanced pancreatic, esophageal, gastric, or colorectal cancer.
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: SU006668 in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on the investigational drug SU006668 being studied in patients with advanced solid tumors, including breast cancer and colore…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer [Phase 3]
Phase 3 clinical trial comparing two chemotherapy regimens with observation in patients who have undergone complete surgical resection for p…
-
CLINICAL_TRIALS withdrawal · 2013-12-13Clinical Trial Update: Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas [Phase 2]
A Phase 2 trial evaluating cetuximab plus gemcitabine for pancreatic cancer (locally advanced, metastatic, or recurrent) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Phase 2]
Phase 2 trial evaluating enoxaparin thromboprophylaxis in cancer patients with elevated tissue factor-bearing microparticles has completed w…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Studying Biomarkers in Patients With Pancreatic Cancer
The trial update reports the completion of a biomarker study in patients with pancreatic cancer conducted by Vanderbilt-Ingram Cancer Center…